Antianaerobe Activity of RBX 7644 (Ranbezolid), a New Oxazolidinone, Compared with Those of Eight Other Agents
Open Access
- 1 March 2003
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 47 (3), 1143-1147
- https://doi.org/10.1128/aac.47.3.1143-1147.2003
Abstract
The activity of ranbezolid (RBX 7644), a new oxazolidinone, against 306 anaerobes was compared with those of 11 other agents. The MICs at which 50% of the isolates tested are inhibited and those at which 90% of the isolates tested are inhibited (in micrograms per milliliter) were as follows: ranbezolid, 0.03 and 0.5; linezolid, 2 and 4; vancomycin, >16 and >16; teicoplanin, 1 and >16; quinupristin-dalfopristin, 1 and >8; amoxicillin-clavulanate, 0.5 and 2; imipenem, 0.125 and 1; clindamycin, 0.25 and 8; metronidazole, 1 and 4; gatifloxacin, 0.5 and 4; and moxifloxacin, 0.5 and 2, respectively. Ranbezolid had very good in vitro activity against both gram-negative and -positive anaerobes.Keywords
This publication has 11 references indexed in Scilit:
- Anti-anaerobic activity of AZD2563, a new oxazolidinone, compared with eight other agents.Journal of Antimicrobial Chemotherapy, 2002
- Comparative Antianaerobic Activity of BMS 284756Antimicrobial Agents and Chemotherapy, 2001
- Quinupristin/dalfopristin and linezolid: where, when, which and whether to use?Journal of Antimicrobial Chemotherapy, 2000
- OxazolidinonesDrugs, 2000
- Linezolid Activity Compared to Those of Selected Macrolides and Other Agents against Aerobic and Anaerobic Pathogens Isolated from Soft Tissue Bite Infections in HumansAntimicrobial Agents and Chemotherapy, 1999
- The in-vitro activity of linezolid (U-100766) and tentative breakpointsJournal of Antimicrobial Chemotherapy, 1998
- Activities of Gatifloxacin Compared to Those of Seven Other Agents against Anaerobic OrganismsAntimicrobial Agents and Chemotherapy, 1998
- Susceptibilities of 394 Bacteroides fragilis, non-B. fragilis group Bacteroides species, and Fusobacterium species to newer antimicrobial agentsAntimicrobial Agents and Chemotherapy, 1991
- Characterization of beta-lactamases from non-Bacteroides fragilis group Bacteroides spp. belonging to seven species and their role in beta-lactam resistanceAntimicrobial Agents and Chemotherapy, 1990
- Beta-lactamase production and susceptibilities to amoxicillin, amoxicillin-clavulanate, ticarcillin, ticarcillin-clavulanate, cefoxitin, imipenem, and metronidazole of 320 non-Bacteroides fragilis Bacteroides isolates and 129 fusobacteria from 28 U.S. centersAntimicrobial Agents and Chemotherapy, 1990